Cargando…

Quantification of late gadolinium enhanced CMR in viability assessment in chronic ischemic heart disease: a comparison to functional outcome

BACKGROUND: Quantification of late gadolinium enhanced cardiovascular magnetic resonance (LGE CMR) by objective window setting increases reproducibility and facilitates multicenter comparison and cooperation. So far, quantification methods or models have only been validated to postmortem animal stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beek, Aernout M, Bondarenko, Olga, Afsharzada, Farshid, van Rossum, Albert C
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2657135/ https://www.ncbi.nlm.nih.gov/pubmed/19272147 http://dx.doi.org/10.1186/1532-429X-11-6

Ejemplares similares

Parametric imaging of myocardial viability using (15)O-labelled water and PET/CT: comparison with late gadolinium-enhanced CMR
por: de Haan, Stefan, et al.
Publicado: (2012)

Comparison of electroanatomic voltage mapping with late gadolinium enhancement CMR
por: Peters, Dana C, et al.
Publicado: (2014)

Stress perfusion CMR in hypertrophic cardiomyopathy: comparison with late gadolinium enhancement
por: Villa, Adriana, et al.
Publicado: (2014)

Quantification of myocardial scar assessed by late gadolinium enhancement CMR in the multi-ethnics study of atherosclerosis: comparisons of 7 different methods
por: Rizzi, Patricia B, et al.
Publicado: (2013)

Association of Whole-Heart Myocardial Mechanics by Transthoracic Echocardiography with Presence of Late Gadolinium Enhancement by CMR in Non-Ischemic Dilated Cardiomyopathy
por: Mėlinytė-Ankudavičė, Karolina, et al.
Publicado: (2022)

CMR - Late gadolinium enhancement characteristics associated with monomorphic ventricular arrhythmia in patients with non-ischemic cardiomyopathy
por: Rajinthan, Priyanka, et al.
Publicado: (2022)

Relationship between clinical features and the diagnostic value of CMR tissue characterisation in patients with clinically suspected myocarditis
por: Biesbroek, Stefan P, et al.
Publicado: (2015)

Correlation between septal midwall late gadolinium enhancement on CMR and conduction delay on ECG in patients with nonischemic dilated cardiomyopathy
por: Becker, Marthe A.J., et al.
Publicado: (2020)

Role of Late Gadolinium Enhancement in the Assessment of Myocardial Viability
por: Shah, Dr. Viraj, et al.
Publicado: (2022)

Can the outcome of post partum cardiomyopathy be predicted using late gadolinium enhancement CMR?
por: Roussin, Isabelle, et al.
Publicado: (2013)

Prognostic significance of ventricular function and late gadolinium enhancement on CMR in symptomatic patients with scleroderma
por: Natarajan, Arun, et al.
Publicado: (2013)

Exclusion of prognostic coronary disease in LV dysfunction using late gadolinium enhancement CMR
por: Thompson, Alexandra, et al.
Publicado: (2015)

Can the outcome of post partum cardiomyopathy be predicted using late gadolinium enhancement CMR?
por: Roussin, Isabelle, et al.
Publicado: (2009)

Patients with acute myocarditis and preserved systolic left ventricular function: comparison of global and regional longitudinal strain imaging by echocardiography with quantification of late gadolinium enhancement by CMR
por: Meindl, Christine, et al.
Publicado: (2021)

3D whole-heart phase sensitive inversion recovery CMR for simultaneous black-blood late gadolinium enhancement and bright-blood coronary CMR angiography
por: Ginami, Giulia, et al.
Publicado: (2017)

Ischemic and non-ischemic patterns of late gadolinium enhancement in heart failure with reduced ejection fraction
por: Matusik, Patrycja S., et al.
Publicado: (2021)

Additive prognostic value of red cell distribution width over late gadolinium enhancement on CMR in patients with non-ischemic dilated cardiomyopathy
por: Yi, Jeong-Eun, et al.
Publicado: (2020)

Feasibility of detecting myocardial infarction in the sheep fetus using late gadolinium enhancement CMR imaging
por: Duan, An Qi, et al.
Publicado: (2017)

Influence of phase correction of late gadolinium enhancement images on scar signal quantification in patients with ischemic and non-ischemic cardiomyopathy
por: Stirrat, John, et al.
Publicado: (2015)

Comparison of Semi-automated Late Gadolinium Enhancement Quantification Techniques in Measuring Septal Fibrosis in Patients with Dilated Non-Ischemic Cardiomyopathy
por: Mikami, Yoko, et al.
Publicado: (2016)

Free-breathing late gadolinium enhancement CMR with a fixed short scan time using CosMo
por: Moghari, Mehdi H, et al.
Publicado: (2012)

Hypertrophic cardiomyopathy and fibrosis: correlation between late gadolinium enhancement on CMR and speckle tracking imaging using Ultrasound
por: Cautela, Jennifer, et al.
Publicado: (2015)

Comparison of gadolinium dose and acquisition time for late gadolinium enhancement at 3.0 T
por: Doltra, Adelina, et al.
Publicado: (2014)

Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics
por: Williams, Lynne K., et al.
Publicado: (2017)

Revisiting how we perform late gadolinium enhancement CMR: insights gleaned over 25 years of clinical practice
por: Jenista, Elizabeth R., et al.
Publicado: (2023)

Quantification of myocardial late gadolinium enhancement using synthetic inversion recovery imaging
por: Varga-Szemes, Akos, et al.
Publicado: (2015)

Beyond late gadolinium enhancement: the key role of diffuse myocardial fibrosis in severe aortic stenosis - an Equilibrium Contrast CMR study
por: Flett, Andrew S, et al.
Publicado: (2011)

Post-infarction ventricular fibrillation mechanisms: Insights from combined body surface potential mapping and late gadolinium-enhanced CMR
por: Cochet, Hubert, et al.
Publicado: (2016)

Incremental Predictive Value of Longitudinal Axis Strain and Late Gadolinium Enhancement Using Standard CMR Imaging in Patients with Aortic Stenosis
por: Agoston-Coldea, Lucia, et al.
Publicado: (2019)

Association of ECG parameters with late gadolinium enhancement and outcome in patients with clinical suspicion of acute or subacute myocarditis referred for CMR imaging
por: Fischer, Kady, et al.
Publicado: (2020)

Quantification of left atrial fibrosis by 3D late gadolinium-enhanced cardiac magnetic resonance imaging in patients with atrial fibrillation: impact of different analysis methods( )
por: Hopman, Luuk H G A, et al.
Publicado: (2021)

Rapid assessment of myocardial infarct size in rodents using multi-slice inversion recovery late gadolinium enhancement CMR at 9.4T
por: Price, Anthony N, et al.
Publicado: (2011)

Appearance of microvascular obstruction on high resolution first-pass perfusion, early and late gadolinium enhancement CMR in patients with acute myocardial infarction
por: Mather, Adam N, et al.
Publicado: (2009)

Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study
por: Pöyhönen, Pauli, et al.
Publicado: (2014)

Impaired myocardial perfusion on CMR is associated with increased numbers of classical monocytes in STEMI patients treated by primary PCI
por: Robbers, Lourens FHJ, et al.
Publicado: (2011)

Late gadolinium enhancement score (LGE-Score) for prediction of extensive late gadolinium enhancement in hypertrophic cardiomyopathy
por: Chan, Raymond H, et al.
Publicado: (2015)

Precision and reproducibility of semi-automated late gadolinium enhancement quantification techniques in patients with hypertrophic cardiomyopathy
por: Mikami, Yoko, et al.
Publicado: (2014)

Accuracy and reproducibility of semi-automated late gadolinium enhancement quantification techniques in patients with hypertrophic cardiomyopathy
por: Mikami, Yoko, et al.
Publicado: (2014)

Assessment of myocardial viability in low signal intensity areas on cine MRI comparison with late gadolinium enhancement imaging in patients with prior myocardial infarction
por: Tanimoto, Takashi, et al.
Publicado: (2012)

Segmental late gadolinium enhancement and gadolinium extracellular volume in hypertrophic cardiomyopathy
por: Levine, Jonathan M, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0s331rdivd5o3ebu5mpacdqeh9